Literature DB >> 19043725

Leprosy pathogenetic background: a review and lessons from other mycobacterial diseases.

Luiz Ricardo Goulart1, Isabela Maria Bernardes Goulart.   

Abstract

Leprosy is a disease caused by Mycobacterium leprae that initially affects the peripheral nervous system with patients exhibiting contrasting clinical, immunological, and pathological manifestations despite minimal genetic variation among bacilli isolates. Its clinical manifestations are related to M. leprae survival, innate and acquired immune responses, and interactions between host and bacterial proteins, preventing their invasion and infection, or promoting their development and pathogenesis. The complex molecular interactions in affected individuals influenced by the pathogenetic background will be explored in this review. However, the great genetic diversity imposes difficulty for understanding disease development, and it is likely that many factors and metabolic pathways regulating the immense and contrasting symptomatology will yet be revealed. Four pathways may play a central role in leprosy, including the TLR/LIR-7, VDR, TNF-alpha, and TGF-beta1 for which a large amount of gene polymorphisms have been described that could potentially affect the clinical outcome. Cross-talk pathways may significantly change the course of the disease, depending on the specific disequilibrium of genic homeostasis, which is highly dependent on the environment, antigens that are presented to the host cell, and specific polymorphisms that interact with other genes, external factors, and pathogen survival, culminating in leprosy occurrence. Currently, the microarray-based genomic survey of gene polymorphisms, multiple gene expression analyses, and proteomic technologies, such as mass spectrometry and phage display applied in the discovery of antigens, represent a great potential for evaluating individual responses of leprosy patients and contacts to predict the outcome and progression of the disease. At present, none of the genes is good prognostic marker; however, in the near future we may use multiple targets to predict infection and leprosy development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19043725     DOI: 10.1007/s00403-008-0917-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  Lepromatous phlebitis of the left external jugular vein.

Authors:  Surinder Thakur; Guman Singh Negi; Irappa Madabhavi; Swaroop Revannasiddaiah
Journal:  BMJ Case Rep       Date:  2012-02-25

Review 2.  Biomarkers for Detecting Resilience against Mycobacterial Disease in Animals.

Authors:  Kathryn Wright; Karren Plain; Auriol Purdie; Bernadette M Saunders; Kumudika de Silva
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

3.  T regulatory cells (TREG)(TCD4+CD25+FOXP3+) distribution in the different clinical forms of leprosy and reactional states.

Authors:  José Napoleão Tavares Parente; Carolina Talhari; Antônio Pedro Mendes Schettini; Cesare Massone
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

4.  Use of Approximate Bayesian Computation to Assess and Fit Models of Mycobacterium leprae to Predict Outcomes of the Brazilian Control Program.

Authors:  Rebecca Lee Smith; Yrjö Tapio Gröhn
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

5.  Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts.

Authors:  Diogo Fernandes Dos Santos; Matheus Rocha Mendonça; Douglas Eulálio Antunes; Elaine Fávaro Pípi Sabino; Raquel Campos Pereira; Luiz Ricardo Goulart; Isabela Maria Bernardes Goulart
Journal:  PLoS Negl Trop Dis       Date:  2018-05-21

6.  Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy.

Authors:  Marlice Fernandes de Oliveira; Douglas Eulálio Antunes; Diogo Fernandes Dos Santos; Isabela Maria Bernardes Goulart
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

Review 7.  Tumour necrosis factor gene polymorphism and disease prevalence.

Authors:  T Qidwai; F Khan
Journal:  Scand J Immunol       Date:  2011-12       Impact factor: 3.487

8.  Quantitative PCR for leprosy diagnosis and monitoring in household contacts: A follow-up study, 2011-2018.

Authors:  Fernanda S N Manta; Raquel R Barbieri; Suelen J M Moreira; Paulo T S Santos; José A C Nery; Nádia C Duppre; Anna M Sales; Antônio G Pacheco; Mariana A Hacker; Alice M Machado; Euzenir N Sarno; Milton O Moraes
Journal:  Sci Rep       Date:  2019-11-13       Impact factor: 4.379

9.  Active surveillance of Hansen's Disease (leprosy): importance for case finding among extra-domiciliary contacts.

Authors:  Maria L N Moura; Kathryn M Dupnik; Gabriel A A Sampaio; Priscilla F C Nóbrega; Ana K Jeronimo; Jose M do Nascimento-Filho; Roberta L Miranda Dantas; Jose W Queiroz; James D Barbosa; Gutemberg Dias; Selma M B Jeronimo; Marcia C F Souza; Maurício L Nobre
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14

10.  Association of the polymorphism of the vitamin D receptor gene (VDR) with the risk of leprosy in the Brazilian Amazon.

Authors:  Jasna Letícia Pinto Paz; Maria do Perpétuo Socorro Corrêa Amador Silvestre; Letícia Siqueira Moura; Ismari Perini Furlaneto; Yan Corrêa Rodrigues; Karla Valéria Batista Lima; Luana Nepomuceno Gondim Costa Lima
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.